Search Results - "HATFIELD, Alan"

The effects of imatinib on pregnancy outcome by Pye, Seonaid M., Cortes, Jorge, Ault, Patricia, Hatfield, Alan, Kantarjian, Hagop, Pilot, Richard, Rosti, Gianantonio, Apperley, Jane F.

“…Imatinib has now been in use for almost 10 years. Despite this cumulative experience, little is known about its effects on pregnancy; as a result, there are…”
Get full text

In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate' by Hatfield, Alan, Owen, Samantha, Pilot, Paul Richard

Get full text

Pain and Its Treatment in Outpatients with Metastatic Cancer by Cleeland, Charles S, Gonin, Rene, Hatfield, Alan K, Edmonson, John H, Blum, Ronald H, Stewart, James A, Pandya, Kishan J

“…Pain is the most persistent and incapacitating symptom of recurrent or metastatic cancer. A large proportion of patients with metastatic cancer have pain long…”
Get full text

A phase III study of radiation therapy plus carmustine with or without recombinant interferon‐α in the treatment of patients with newly diagnosed high‐grade glioma by Buckner, Jan C., Schomberg, Paula J., McGinnis, William L., Cascino, Terrence L., Scheithauer, Bernd W., O'Fallon, Judith R., Morton, Roscoe F., Kuross, Steven A., Mailliard, James A., Hatfield, Alan K., Cole, John T., Steen, Preston D., Bernath, Albert M.

“…BACKGROUND The current study was conducted to determine whether the addition of interferon‐α (IFN‐α) to treatment with radiation therapy and carmustine (BCNU)…”
Get full text

Megestrol Acetate for the Prevention of Hot Flashes by Loprinzi, Charles L, Michalak, John C, Quella, Susan K, O'Fallon, Judith R, Hatfield, Alan K, Nelimark, Robert A, Dose, Ann Marie, Fischer, Tammy, Johnson, Claudia, Klatt, Nancy E, Bate, Walter W, Rospond, Raylene M, Oesterling, Joseph E

“…Vasomotor hot flashes occur commonly in menopausal women. In addition, they are the most frequent side effect associated with the antiestrogen drug tamoxifen 1…”
Get full text

A Simple Stratification Factor Prognostic for Survival in Advanced Cancer: The Good/Bad/Uncertain Index by SLOAN, Jeff A, LOPRINZI, Charles L, WIESENFELD, Martin, TSCHETTER, Loren K, HATFIELD, Alan K, SCHAEFER, Paul L, LAURINE, John A, NOVOTNY, Paul J, VARGAS-CHANES, Delfino, KROOK, James E, O'CONNELL, Michael J, KUGLER, John W, TIRONA, Maria Tria, KARDINAL, Carl G

“…This article summarizes the third step of a research program to identify variables that supplement the predictive power of the the Eastern Cooperative Oncology…”
Get full text

Alternating chemotherapy with etoposide plus cisplatin and topotecan plus paclitaxel in patients with untreated, extensive-stage small cell lung carcinoma: A Phase II trial of the north central cancer treatment group by JETT, James R, HATFIELD, Alan K, HILLMAN, Shauna, BAUMAN, Michael D, MAILLIARD, James A, KUGLER, John W, MORTON, Roscoe F, MARKS, Randolph S, LEVITT, Ralph

“…The objective of this study was to test the response rate and toxicity of alternating chemotherapy in previously untreated patients with extensive-stage small…”
Get full text

Prediction of node-negative breast cancer outcome by histologic grading and S-phase analysis by flow cytometry : An Eastern Cooperative Oncology Group Study (2192) by PAGE, David L, GRAY, Robert, ALLRED, D. Craig, DRESSIER, Lynn G, HATFIELD, Alan K, MARTINO, Silvana, ROBERT, Nicholas J, WOOD, William C

“…Histologic evaluation and reporting of invasive breast cancer has effectively used Nottingham combined histologic grade (NCHG). This approach to predict…”
Get full text

Phase II Study of Cisplatin and Paclitaxel in Advanced Carcinoma of the Urothelium: An Eastern Cooperative Oncology Group Study by DREICER, R, MANOLA, J, ROTH, B. J, COHEN, M. B, HATFIELD, A. K, WILDING, G

“…Cisplatin and paclitaxel are active agents in advanced urothelial cancer. A phase II trial of this combination was performed to determine the activity and…”
Get full text

Phase II study of oral etoposide and intravenous paclitaxel in extensive-stage small cell lung cancer by Perez, Edith A, Geoffroy, Francois J, Hillman, Shauna, Johnson, Elizabeth A, Farr, Gist H, Tazelarr, Henry D, Hatfield, Alan K, Krook, James E, Maillard, James A, Levitt, Ralph, Marks, Randolph S

“…Background: This study evaluated the activity and tolerance for the combination of oral etoposide and paclitaxel as first-line therapy for patients with…”
Get full text

A north central cancer treatment group Phase II trial of 9‐aminocamptothecin in previously untreated patients with measurable metastatic colorectal carcinoma by Pitot, Henry C., Knost, James A., Mahoney, Michelle R., Kugler, John, Krook, James E., Hatfield, Alan K., Sargent, Daniel J., Goldberg, Richard M.

“…BACKGROUND Topoisomerase I inhibitors have demonstrated clinical activity in patients with metastatic colorectal carcinoma. The authors performed a Phase II…”
Get full text

Long-term survival of patients with advanced/recurrent carcinoma of cervix and vagina after neoadjuvant treatment with methotrexate, vinblastine, doxorubicin, and cisplatin with or without the addition of molgramostim, and review of the literature by LONG, Harry J, RAYSON, Sandra, PODRATZ, Karl C, ABU-GHAZALEH, Samir, SUMAN, Vera, HARTMANN, Lynn C, LEVITT, Ralph, NAIR, Suresh, HATFIELD, Alan K, KNOST, James A

“…A randomized phase III study was conducted to assess the addition of molgramostim (GM-CSF) to the combination of methotrexate, vinblastine, doxorubicin, and…”
Get full text

A randomized phase II trial of two schedules of topotecan for the treatment of advanced stage non-small cell lung cancer by Weitz, John J, Marschke, Robert F, Sloan, Jeff A, Grill, Joseph P, Jett, James R, Knost, James A, Hatfield, Alan K, Zenk, David W, Bate, Walter W, Schaefer, Paul L

“…We conducted a randomized phase II trial of two different schedules of topotecan in patients with advanced-stage non small lung cancer (NSCLC) without prior…”
Get full text

Treatment interruptions and non-adherence with imatinib and associated healthcare costs : A retrospective analysis among managed care patients with chronic myelogenous leukaemia by DARKOW, Theodore, HENK, Henry J, THOMAS, Simu K, WEIWEI FENG, BAIADI, Jean-Francois, GOLDBERG, George A, HATFIELD, Alan, CORTES, Jorge

“…Identify treatment interruptions and non-adherence with imatinib; examine the clinical and patient characteristics related to treatment interruptions and…”
Get full text

Phase III Evaluation of Octreotide versus Chemotherapy with 5-Fluorouracil or 5-Fluorouracil Plus Leucovorin in Advanced Exocrine Pancreatic Cancer: A North Central Cancer Treatment Group Study by BURCH, Patrick A, BLOCK, Margaret, KUROSS, Steven A, SCHROEDER, Georgene, KUGLER, John W, SARGENT, Daniel J, BRAICH, Theodore A, MAILLIARD, James A, MICHALAK, John C, HATFIELD, Alan K, WRIGHT, Keith

“…There continues to be a need for new systemic approaches for the treatment of advanced pancreatic cancer. The purpose of this study was to compare the…”
Get full text

A randomized clinical trial of two different durations of oral cryotherapy for prevention of 5-fluorouracil-related stomatitis by Rocke, L K, Loprinzi, C L, Lee, J K, Kunselman, S J, Iverson, R K, Finck, G, Lifsey, D, Glaw, K C, Stevens, B A, Hatfield, A K

“…The authors previously reported that 30 minutes of oral cryotherapy inhibits 5-fluorouracil (5-FU)-induced stomatitis. The current trial was designed to…”
Get more information

Comparison of Conventional Dose and Double Dose Carboplatin in Patients Receiving Cyclophosphamide Plus Carboplatin for Advanced Ovarian Carcinoma: A North Central Cancer Treatment Group Study by Edmonson, John H., Suman, Vera J., Dalton, Robert J., Bro, Walter C., Gallenberg, Mary M., Long, Harry J., Levitt, Ralph, Hatfield, Alan K., Krook, James E., Mailliard, James A., Gerstner, James B.

“…Between March 1992 and November 1994, 91 patients with stage III and IV ovarian carcinoma were enrolled in a randomized comparative study of cyclophosphamide…”
Get full text

In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate' by Gambacorti, Carlo, Tornaghi, Lucia, Franceschino, Anna, Piazza, Rocco, Corneo, Gianmarco, Pogliani, Enrico

Get full text

Development of Anticipatory Nausea: A Prospective Analysis by Andrykowski, Michael A, Redd, William H, Hatfield, Alan K

“…The development of anticipatory nausea in cancer chemotherapy typically has been viewed in terms of a respondent learning model. Firm support for this…”
Get full text

Accidental and Intentional Overdose of Imatinib: a Report of Outcome and Side Effect of 46 Cases by Guilhot, François, Hatfield, Alan K., Millot, Frederic, Roy, Lydia, Molimard, Mathieu, Cui, Jean

“…Abstract 4273 In the initial phase I trials maximum tolerated dose with imatinib was not reached. However based on the clinical results, imatinib at doses of…”
Get full text